Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to fall 1.39% to -35 cents per share on March 19
Q4'25
Est.
$-0.35
Q3'25
Beat
by $0.02
Q2'25
Beat
by $0.07
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.04
The last earnings report on November 04 showed earnings per share of -36 cents, beating the estimate of -38 cents. With 715.10K shares outstanding, the current market capitalization sits at 44.80M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HOWL showed earnings on November 04, 2025. You can read more about the earnings report here.